Abstract
The objective of this study was to evaluate the oesophageal dysfunction in patients with “early” systemic sclerosis (SSc), as defined by LeRoy and Medsger, to compare it with that of patients with definite SSc, and to correlate it with other features of the disease. Oesophageal manometry results were retrospectively evaluated in 181 patients classified by the 2001 LeRoy and Medsger criteria and the 1980 American College of Rheumatology (ACR) criteria: group 1: limited SSc: Raynaud’s phenomenon plus specific nailfold capillaroscopy abnormalities and/or autoantibodies; group 2: limited cutaneous SSc not satisfying the ACR criteria (lcSSc ACR−); group 3: lcSSc ACR+; group 4: diffuse cutaneous SSc. Peristaltic abnormalities in the oesophageal body were present in 73 of 125 patients with SSc ACR+ (groups 3 and 4) compared with 13 of 56 with SSc ACR− (groups 1 and 2) (p<0.0001). They were more severe in patients with more advanced disease (1 vs 2; 1 vs 3; 1 vs 4; 2 vs 4; p<0.05) and in patients anti-Scl-70+ than in patients anticentromere positive (p=0.02). Abnormalities of the lower oesophageal sphincter (LES) were present in 35 of 125 patients with SSc ACR+ and 11 of 56 with SSc ACR− (not statistically different). They were correlated with forced vital capacity (FVC) (LES pressure: p=0.0005; LES length: p=0.0004). Abnormalities of the oesophageal body and of the LES were found in 21 and 16% of 46 patients without oesophageal symptoms. Oesophageal manometry can detect abnormalities in a sizeable proportion of patients with “early SSc” not fulfilling the ACR criteria, including asymptomatic patients. The correlation between LES abnormalities and FVC suggests a possible causal relationship between these disease manifestations.
Similar content being viewed by others
References
Sjoegren R (1994) Gastrointestinal motility disorders in systemic sclerosis. Arthritis Rheum 37:1265–1282
Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum 23:581–590
Kallenberg CGM, Wouda AA, Hoet HM, van Venroij WJ (1988) Development of connective tissue disease in patients presenting with Raynaud’s phenomenon: a six-year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 47:634–641
Weiner ES, Hildebrandt S, Senecal JL et al (1991) Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud’s disease. A prospective study. Arthritis Rheum 34:68–77
Medsger TA Jr (1985) Comment on scleroderma criteria cooperative study. In: Black CM, Myers AR (eds) Current topics in rheumatology: systemic sclerosis (scleroderma). Gower Medical Publishing, New York, pp 16–17
Scussel-Lonzetti L, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44:735–736
LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576
Wigley FM (2001) When is scleroderma really scleroderma? J Rheumatol 28:1471–1473
LeRoy EC, Black C, Fleischmayer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–208
Maricq HR (1981) Wide-field capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24:1159–1165
Maricq HR, Harper FE, Khan EM, Tan EM, LeRoy EC (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1:195–205
Bernstein RM, Bunn CC, Hughes GRV (1982) Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann Rheum Dis 41:554–555
Pope CE II (1992) The quality of life following antireflux surgery. World J Surg 16:335–358
Henry MACA, Harbermann MC, Rocha OM (1999) Esophageal motor disturbance in progressive systemic sclerosis. Dis Esophagus 12:51–53
Dodds WJ, Hogan WJ, Steff JJ, Miller WN, Arndorfer RC (1975) A rapid pull-through technique for measuring lower esophageal sphincter pressure. Gastroenterology 68:437–443
Bassotti G, Bacci G, Biagini D, David P, Alunni G, Pelli MA (1988) Manometric evaluation of the entire esophagus in healthy subjects and patients with high amplitude peristaltic contractions. Dysphagia 3:93–96
Winans CS, Harris LD (1967) Quantitation of lower esophageal sphincter competence. Gastroenterology 52:773–778
Castell JA (1987) The computer in the motility laboratory. In: Castell DO, Richetr JE, Dalton CB (eds) Esophageal motility testing. Elsevier, New York
Doria A, Bonavina L, Anselmino M et al (1991) Esophageal involvement in mixed connective tissue disease. J Rheumatol 18:685–690
Orlowski J, Dodds WJ, Linehan JH, Dent J, Hogan WJ, Amdorfer RC (1982) Requirements for accurate manometric recording of pharyngeal and esophageal peristaltic pressure waves. Invest Radiol 17:567–572
Richter JE, Wu WC, Johns DN et al (1987) Esophageal manometry in 95 healthy adult volunteers. Dig Dis Sci 32:583–592
Passaretti S, Baldi F, Costantini M, Di Martino N, Leo P, Zaninotto G (2000) Manometria esofagea. Farmaci 24:7–18
American Gastroenterological Association (1994) Technical review on the clinical use of esophageal manometry. Gastroenterology 107:1865–1884
Evans DF, Buckton GK (1999) Clinical measurement in gastroenterology. In: The esophagus. Blackwell Science Ltd, Oxford
Cotes JE, Chinn DJ, Roca J, Quanjer PH, Yernault JC (1993) Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J 16 [Suppl]:41–52
Quanjer PH, Tammerling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1994) Lung volumes and forced ventilatory flows. Rev Mal Respir 11:5–40
Weihrauch TR, Korting GW (1982) Manometric assessment of oesophageal involvement in progressive systemic sclerosis, morphoea and Raynaud’s disease. Br J Dermatol 107:325–332
Hamel-Roy J, Devroede G, Arhan P, Tetreault L, Duranceau A, Menard HA (1985) Comparative esophageal and anorectal motility in scleroderma. Gastroenterology 88:1–7
Tsianos EB, Drosos AA, Chiras CD, Moutsopulos HM, Kitridou R (1987) Esophageal manometric findings in autoimmune rheumatic diseases: is scleroderma esophagus a specific entity? Rheumatol Int 7:23–27
Akesson A, Wollheim FA (1989) Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between CREST syndrome and diffuse scleroderma. Br J Rheumatol 28:281–286
Yarze JC, Varga J, Stampfl D, Castell DO, Jimenez SA (1993) Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol 88:870–876
Lapadula G, Muolo P, Semeraro F et al (1994) Esophageal dysmotility disorders in the rheumatic diseases: a review of 150 patients. Clin Exp Rheumatol 12:515–521
Bassotti G, Battaglia E, Debernardi V et al (1997) Esophageal dysfunction in scleroderma. Relationship with disease subsets. Arthritis Rheum 40:2252–2259
Krieg T, Meurer M (1988) Systemic scleroderma: clinical and pathophysiologic aspects. J Am Acad Dermatol 18:457–481
Koshino Y, Takai T, Kato T et al (1991) Manometric evaluation of esophageal function in progressive systemic sclerosis with special regard to disease severity. Gastroenterol Jpn 26:575–581
Giordano M, Valentini G, Migliaresi S, Picillo U, Vatti M (1986) Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 13:911–916
Poormoghim H, Lucas M, Fertig N, Mesdger TA Jr (2000) Systemic sclerosis sine scleroderma. Arthritis Rheum 43:444–451
Hostein J, Bost R, Carpentier P, Franco A, Fornet J (1985) Motricité oesophagienne au cours de la maladie de Raynaud, de la sclérodermie systémique et du syndrome de Raynaud présclérodermique. Gastroenterol Clin Biol 9:130–135
Kinuya K, Nakajima K, Kinuya S, Michigishi T, Tonami N, Takehara K (2001) Esophageal hypomotility in systemic sclerosis: close relationship with pulmonary involvement. Ann Nucl Med 15:97–101
Gonzalez R, Storr M, Bloching H, Seige M, Ott R, Allescher HD (2001) Autoantibody profile in systemic sclerosis as markers for esophageal involvement. J Clin Gastroenterol 32:123–127
Denis P, Ducrotte P, Pasquis P, Lefrançois R (1981) Esophageal motility and pulmonary function in progressive systemic sclerosis. Respiration 42:21–24
Marie I, Dominique S, Levesque H et al (2001) Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 45:346–354
Troshinsky MB, Kane GC, Varga J et al (1994) Pulmonary function and gastroesophageal reflux in systemic sclerosis. Ann Intern Med 121:6–10
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Airò, P., Della Casa, D., Danieli, E. et al. Oesophageal manometry in early and definite systemic sclerosis. Clin Rheumatol 24, 370–376 (2005). https://doi.org/10.1007/s10067-004-1049-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-004-1049-6